Theophylline Tablet, Extended Release
Product Images NDC 72789-441

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Theophylline (NDC 72789-441). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

72789441 Label (72789441)

72789441 Label (72789441)
This is a description for a pharmaceutical product - an extended-release tablet containing 300 mg of Theophylline (Anhydrous). The suggested dosage information is not provided in the text, and it directs users to refer to the package insert for more details. The tablets are manufactured by Strides Pharma Science Limited in Bengaluru, India, and inquiries should be directed to PD-Rx Pharmaceuticals, Inc. based in Oklahoma City. The tablets should be stored at controlled room temperature and dispensed in a well-closed container with child-resistant closure. The product information includes various identification numbers such as NDC, GTIN, SNO, and LOT, with an expiration date of 08/2026. The product is designated for prescription use only.*
FDA Label Image

Structure-theophylline (7487d300 1a59 4410 84ae 8a36b24b15a9 01)

Structure-theophylline (7487d300 1a59 4410 84ae 8a36b24b15a9 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.